RHO and cancer: The discovery of a novel series of oxadiazole-thioether CCG-molecules, inhibitors of the Rho/MRTF/SRF transcription pathway, has implicated their role in preventing cancer cell migration in vitro and improving fibrosis in vivo [26,27].